LINDSAY DELMONT: Open Payments
NPI 1477707461 · SAINT JOSEPH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,414 in 127 payments from 20 companies in 2025. Trend: 2023 $2,518 · 2024 $3,314 · 2025 $2,414
Food & beverage: $2,414
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $420 |
| Galderma Laboratories, L.P. | 18 | $314 |
| Amgen Inc. | 12 | $249 |
| Novartis Pharmaceuticals Corporation | 11 | $226 |
| UCB, Inc. | 8 | $161 |
| Almirall LLC | 9 | $157 |
| LEO Pharma Inc. | 7 | $139 |
| Janssen Biotech, Inc. | 5 | $95 |
| Lilly USA, LLC | 5 | $93 |
| Regeneron Healthcare Solutions, Inc. | 4 | $89 |
Products named: OTEZLA, SKYRIZI, NEMLUVIO, COSENTYX, RINVOQ, Bimzelx, Seysara, ADBRY.
Industry payments across MO — which companies pay providers there.
